🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will evaluate a gene expression signature (Growth Factor Signatu...
Status
Terminated
Location
Multiple Locations
Start Date
2009-06
Trial ID
NCT00860535
Treatments Being Tested
The purpose of this study is to compare the efficacy and safety of 2 starti...
Status
Terminated
Location
Cliniques Universitaire Saint-Luc (Site 058)
Start Date
2015-12-31
Trial ID
NCT02627677
Treatments Being Tested
The MOST Plus study is a two-period phase II clinical trial, conducted in p...
Status
Recruiting
Location
Institut Bergonié
Start Date
2014-03
Trial ID
NCT02029001
The purpose of this study is to explore the efficacy of nilotinib as a trea...
Status
Completed
Location
Institut Bergonié
Start Date
2010-12
Trial ID
NCT01261429
Treatments Being Tested
The goal of this clinical research study is to learn if Tasigna® (nilotinib...
Status
Withdrawn
Location
Multiple Locations
Start Date
2011-01
Trial ID
NCT01270893
Treatments Being Tested
The purpose of this program is to allow access to nilotinib for eligible pa...
Status
No Longer Available
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT04498871
Treatments Being Tested
Major response was observed to imatinib mesylate in KIT-mutated metastatic ...
Status
Completed
Location
Samsung Cancer Center
Start Date
2009-08
Trial ID
NCT01099514
Treatments Being Tested
whether Nilotinib at the two sequential dosage forms will induce quicker an...
Status
Terminated
Location
National Guard Hospital
Start Date
2013-03
Trial ID
NCT02086487
Treatments Being Tested
The goal of this clinical research study is to learn if an experimental age...
Status
Completed
Location
University of Texas MD Anderson Cancer Center
Start Date
2005-06-27
Trial ID
NCT00129740
Treatments Being Tested
The study evaluated the safety and efficacy of nilotinib versus current tre...
Status
Completed
Location
UCLA's Jonsson Comprehensive Cancer Center
Start Date
2007-03
Trial ID
NCT00471328
Treatments Being Tested